Filtered By:
Condition: SARS
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 1917 results found since Jan 2013.
Overcoming severe adverse reactions to venom immunotherapy using anti ‐IgE antibodies in combination with a high maintenance dose
Conclusions and Clinical RelevanceCombining a temporary omalizumab therapy with an elevated maintenance dose seems a promising approach to achieve a tolerance of treatment in patients with a recurrent SAR to VIT.
Source: Clinical and Experimental Allergy - September 28, 2017 Category: Allergy & Immunology Authors: E. Stretz, E. M. Oppel, H. ‐C. Räwer, R. Chatelain, S. Mastnik, B. Przybilla, F. Ruëff Tags: ORIGINAL ARTICLE Source Type: research
Component-resolved diagnosis in selecting patients for yellowjacket venom immunotherapy
Venom immunotherapy is effective in preventing systemic allergic reactions (SARs), but the diagnosis of venom allergy is problematic.
Source: Annals of Allergy, Asthma and Immunology - January 31, 2018 Category: Allergy & Immunology Authors: Anna Kaarina Kukkonen, Anna Susanna Pelkonen, Sanna Marika Edelman, Paula Maria Kauppi, Mika Juhani M äkelä Source Type: research
World Allergy Organization Grading System for Systemic Allergic Reactions: it Is Time to Speak the Same Language When it Comes to Allergic Reactions
AbstractPurpose of reviewTo discuss current methods for grading severe allergic reactions (SARs) in view of the new WAO modified classification system.Recent findingsWhile there is not universally accepted system for classifying SAR severity, and due to the high degree of heterogeneity and difficulties for comparisons between the various methods, the new WAO proposal is simple, suitable for use in clinical practice and universally applicable for all allergic reactions, covering the full spectrum of possible grades of severity.SummaryThere is a requirement for a simple and comprehensive system to classify systemic allergic ...
Source: Current Treatment Options in Allergy - September 12, 2019 Category: Allergy & Immunology Source Type: research
Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection
Publication date: Available online 18 April 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Brian Lipworth, Rory Chan, Samuel Lipworth, Chris RuiWen Kuo
Source: The Journal of Allergy and Clinical Immunology: In Practice - April 19, 2020 Category: Allergy & Immunology Source Type: research
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
The novel coronavirus SARS-CoV-2 (COVID-19) was recognized in December 2019 as a cause of severe pneumonia and has now led to a global pandemic.1 Respiratory illnesses caused by COVID-19 cover a range of severity. The identification of risk and protective factors for disease severity from COVID-19 is critical to direct development of new treatments and infection prevention strategies. Early large case series have identified a number of risk factors for severe disease, including older age, hypertension, diabetes, cardiovascular disease, tobacco exposure, and chronic obstructive pulmonary disease.
Source: Journal of Allergy and Clinical Immunology - April 21, 2020 Category: Allergy & Immunology Authors: Daniel J. Jackson, William W. Busse, Leonard B. Bacharier, Meyer Kattan, George T. O ’Connor, Robert A. Wood, Cynthia M. Visness, Stephen R. Durham, David Larson, Stephane Esnault, Carole Ober, Peter J. Gergen, Patrice Becker, Alkis Togias, James E. Ger Tags: Letter to the Editor Source Type: research
Severe Acute Respiratory Syndrome Coronavirus 2: Genomic Observations and Emerging Therapies
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - May 5, 2020 Category: Respiratory Medicine Authors: Walter Dehority Dominique Spence Darrell L. Dinwiddie Source Type: research
Type 2 Inflammation Modulates ACE2 and TMPRSS2 in Airway Epithelial Cells
Capsule Summary: ACE2 and TMPRSS2 are required for cell entry by SARS-CoV-2. The expression of ACE2 and TMPRSS2 in asthma and allergy is modulated by IL-13. Whether this affects susceptibility to COVID-19 requires further study.
Source: Journal of Allergy and Clinical Immunology - May 13, 2020 Category: Allergy & Immunology Authors: Hiroki Kimura, Dave Francisco, Michelle Conway, Fernando D. Martinez, Donata Vercelli, Francesca Polverino, Dean Billheimer, Monica Kraft Source Type: research
Options for Personal Protective Equipment During the SARS-CoV-2 Pandemic Used in New Orleans, Louisiana
Publication date: Available online 30 May 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): John C. Carlson
Source: The Journal of Allergy and Clinical Immunology: In Practice - May 31, 2020 Category: Allergy & Immunology Source Type: research
Primary prevention
Nearly a year ago, the editors at the Annals of Allergy, Asthma& Immunology decided to put together an issue focused on vaccine technology and the importance of vaccination. At that time, we thought it was best to focus on respiratory virus vaccines (specifically for influenza and respiratory syncytial virus [RSV]), issues related to developing vaccines, and the distressing social movement against vaccination. Coronaviruses were not even considered. Now, we find ourselves in the middle of a pandemic created by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with a rush to develop a ...
Source: Annals of Allergy, Asthma and Immunology - June 19, 2020 Category: Allergy & Immunology Authors: Mitchell H. Grayson Tags: Editorial Source Type: research
Early experiences of SARS-CoV2 infection in severe asthmatics receiving biologic therapy
Publication date: Available online 24 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Javier Domínguez-Ortega, Valentín López-Carrasco, Pilar Barranco, Mihaela Ifrin, Juan Alberto Luna, David Romero, Santiago Quirce
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 26, 2020 Category: Allergy & Immunology Source Type: research
SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation
Publication date: Available online 27 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Manon Grandbastien, Anays Piotin, Julien Godet, Ines Abessolo-Amougou, Carole Ederlé, Irina Enache, Philippe Fraisse, Thi Cam Tu Hoang, Loic Kassegne, Aissam Labani, Pierre Leyendecker, Louise Manien, Christophe Marcot, Guillaume Pamart, Benjamin Renaud-Picard, Marianne Riou, Virginie Doyen, Romain Kessler, Samira Fafi-Kremer, Carine Metz-Favre
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 29, 2020 Category: Allergy & Immunology Source Type: research
Lack of Complications in Patients with Eosinophilic Gastrointestinal Diseases During SARS-CoV-2 Outbreak
Publication date: Available online 29 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Edoardo Savarino, Greta Lorenzon, Matteo Ghisa, Giorgio Laserra, Brigida Barberio, Daria Maniero Sc, Vincenzo Savarino, Fabiana Zingone
Source: The Journal of Allergy and Clinical Immunology: In Practice - June 30, 2020 Category: Allergy & Immunology Source Type: research
Early experiences of SARS-CoV-2 infection in severe asthmatics receiving biologic therapy
Publication date: Available online 24 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Javier Domínguez-Ortega, Valentín López-Carrasco, Pilar Barranco, Mihaela Ifim, Juan Alberto Luna, David Romero, Santiago Quirce
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 2, 2020 Category: Allergy & Immunology Source Type: research
Rapid recovery of a SARS-CoV-2 infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
Publication date: Available online 8 July 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Estefanía Mira, Oscar A. Yarce, Consuelo Ortega, Silvia Fernández, Natalia M. Pascual, Cristina Gómez, Miguel A. Alvarez, Ignacio J. Molina, Rafael Lama, Manuel Santamaria
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 9, 2020 Category: Allergy & Immunology Source Type: research
Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
Publication date: Available online 8 July 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Estefanía Mira, Oscar A. Yarce, Consuelo Ortega, Silvia Fernández, Natalia M. Pascual, Cristina Gómez, Miguel A. Alvarez, Ignacio J. Molina, Rafael Lama, Manuel Santamaria
Source: The Journal of Allergy and Clinical Immunology: In Practice - July 17, 2020 Category: Allergy & Immunology Source Type: research
